Urologic Surgery and Population Health Science, Duke Surgical Center for Outcomes Research, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, MO.
Am J Kidney Dis. 2021 Jun;77(6):898-906.e1. doi: 10.1053/j.ajkd.2020.09.016. Epub 2020 Nov 16.
RATIONALE & OBJECTIVE: Although maintaining high fluid intake is an effective low-risk intervention for the secondary prevention of urinary stone disease, many patients with stones do not increase their fluid intake.
We describe the rationale and design of the Prevention of Urinary Stones With Hydration (PUSH) Study, a randomized trial of a multicomponent behavioral intervention program to increase and maintain high fluid intake. Participants are randomly assigned (1:1 ratio) to the intervention or control arm. The target sample size is 1,642 participants.
SETTING & PARTICIPANTS: Adults and adolescents 12 years and older with a symptomatic stone history and low urine volume are eligible. Exclusion criteria include infectious or monogenic causes of urinary stone disease and comorbid conditions precluding increased fluid intake.
All participants receive usual care and a smart water bottle with smartphone application. Participants in the intervention arm receive a fluid intake prescription and an adaptive program of behavioral interventions, including financial incentives, structured problem solving, and other automated adherence interventions. Control arm participants receive guideline-based fluid instructions.
The primary end point is recurrence of a symptomatic stone during 24 months of follow-up. Secondary end points include changes in radiographic stone burden, 24-hour urine output, and urinary symptoms.
Periodic 24-hour urine volumes may not fully reflect daily behavior.
With its highly novel features, the PUSH Study will address an important health care problem.
National Institute of Diabetes and Digestive and Kidney Diseases.
Registered at ClinicalTrials.gov with study number NCT03244189.
尽管保持高液体摄入是预防尿石病复发的一种有效且低风险的干预措施,但许多结石患者并未增加液体摄入。
我们描述了维持液体摄入预防尿路结石(PUSH)研究的原理和设计,这是一项多组分行为干预方案的随机试验,旨在增加并维持高液体摄入。参与者以 1:1 的比例随机分配到干预组或对照组。目标样本量为 1642 名参与者。
有症状结石史和低尿量的成年人和 12 岁及以上的青少年有资格参加。排除标准包括感染或单基因原因引起的尿石病和妨碍增加液体摄入的合并症。
所有参与者均接受常规护理和带有智能手机应用程序的智能水瓶。干预组的参与者接受液体摄入处方和适应性行为干预方案,包括经济奖励、结构化问题解决和其他自动化依从性干预。对照组的参与者接受基于指南的液体指导。
主要结局是在 24 个月的随访期间复发有症状的结石。次要结局包括放射学结石负担、24 小时尿量和尿症状的变化。
定期的 24 小时尿液量可能无法完全反映日常行为。
PUSH 研究具有创新性,将解决一个重要的医疗保健问题。
美国国立卫生研究院国家糖尿病、消化和肾脏疾病研究所。
ClinicalTrials.gov 注册号为 NCT03244189。